207 related articles for article (PubMed ID: 32979031)
1. Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation.
Valke LLFG; Bukkems LH; Barteling W; Laros-van Gorkom BAP; Blijlevens NMA; Mathôt RAA; van Heerde WL; Schols SEM
J Thromb Haemost; 2020 Dec; 18(12):3222-3231. PubMed ID: 32979031
[TBL] [Abstract][Full Text] [Related]
2. Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A.
Bukkems LH; Valke LLFG; Barteling W; Laros-van Gorkom BAP; Blijlevens NMA; Cnossen MH; van Heerde WL; Schols SEM; Mathôt RAA
Br J Clin Pharmacol; 2022 Jun; 88(6):2757-2768. PubMed ID: 34921439
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic-Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate.
Valke LLFG; Cloesmeijer ME; Mansouritorghabeh H; Barteling W; Blijlevens NMA; Cnossen MH; Mathôt RAA; Schols SEM; van Heerde WL
Eur J Drug Metab Pharmacokinet; 2024 Mar; 49(2):191-205. PubMed ID: 38367175
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation for monitoring hemostatic therapy in hemophilia A: A narrative review.
Verhagen MJA; Valke LLFG; Schols SEM
J Thromb Haemost; 2022 Apr; 20(4):794-805. PubMed ID: 35034413
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic effect of tranexamic acid combined with factor VIII concentrate in prophylactic setting in severe hemophilia A: A preclinical study.
Janbain M; Enjolras N; Bordet JC; Bolbos R; Brevet M; Leissinger C; Dargaud Y
J Thromb Haemost; 2020 Mar; 18(3):584-592. PubMed ID: 31782901
[TBL] [Abstract][Full Text] [Related]
6. High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials.
Shibasaki F; Takeyama M; Ogiwara K; Furukawa S; Nakajima Y; Shimonishi N; Nogami K
Int J Hematol; 2023 May; 117(5):669-677. PubMed ID: 36607560
[TBL] [Abstract][Full Text] [Related]
7. Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia A.
Ninivaggi M; Dargaud Y; van Oerle R; de Laat B; Hemker HC; Lindhout T
J Thromb Haemost; 2011 Aug; 9(8):1549-55. PubMed ID: 21605333
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of low-dose pharmacokinetic-guided extended half-life versus low-dose standard half-life factor VIII concentrate prophylaxis in haemophilia A patients.
Rakmanotham A; Moonla C; Sosothikul D
Haemophilia; 2023 Jan; 29(1):156-164. PubMed ID: 36409282
[TBL] [Abstract][Full Text] [Related]
9. Comparing thrombin generation in patients with hemophilia A and patients on vitamin K antagonists.
de Koning MLY; Fischer K; de Laat B; Huisman A; Ninivaggi M; Schutgens REG
J Thromb Haemost; 2017 May; 15(5):868-875. PubMed ID: 28296129
[TBL] [Abstract][Full Text] [Related]
10. Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa.
van de Berg TW; Beckers EAM; Heubel-Moenen FCJI; Henskens YMC; Thomassen MCLGD; Hackeng TM
Thromb Haemost; 2023 Nov; 123(11):1034-1041. PubMed ID: 37236229
[TBL] [Abstract][Full Text] [Related]
11. Clot waveform analysis using CS-2000i™ distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A.
Matsumoto T; Nogami K; Tabuchi Y; Yada K; Ogiwara K; Kurono H; Arai N; Shima M
Haemophilia; 2017 Sep; 23(5):e427-e435. PubMed ID: 28750470
[TBL] [Abstract][Full Text] [Related]
12. The mild phenotype in severe hemophilia A with Arg1781His mutation is associated with enhanced binding affinity of factor VIII for factor X.
Yada K; Nogami K; Wakabayashi H; Fay PJ; Shima M
Thromb Haemost; 2013 Jun; 109(6):1007-15. PubMed ID: 23467620
[TBL] [Abstract][Full Text] [Related]
13. The factor VIII treatment history of non-severe hemophilia A.
Abdi A; Kloosterman FR; Eckhardt CL; Male C; Castaman G; Fischer K; Beckers EAM; Kruip MJHA; Peerlinck K; Mancuso ME; Santoro C; Hay CR; Platokouki H; van der Bom JG; Gouw SC; Fijnvandraat K; Hart DP;
J Thromb Haemost; 2020 Dec; 18(12):3203-3210. PubMed ID: 32877570
[TBL] [Abstract][Full Text] [Related]
14. A factor IX variant that functions independently of factor VIII mitigates the hemophilia A phenotype in patient plasma.
Strijbis VJF; Romano LGR; Cheung KL; Eikenboom J; Liu YP; McCreary AC; Leebeek FWG; Bos MHA
J Thromb Haemost; 2023 Jun; 21(6):1466-1477. PubMed ID: 36863564
[TBL] [Abstract][Full Text] [Related]
15. A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia A.
Matsumoto T; Nogami K; Ogiwara K; Shima M
Int J Hematol; 2009 Dec; 90(5):576-582. PubMed ID: 19937483
[TBL] [Abstract][Full Text] [Related]
16. Thrombomodulin-modified thrombin generation after in vivo recombinant factor VIII treatment in severe hemophilia A.
Dielis AW; Balliël WM; van Oerle R; Hermens WT; Spronk HM; Ten Cate H; Hamulyák K
Haematologica; 2008 Sep; 93(9):1351-7. PubMed ID: 18641016
[TBL] [Abstract][Full Text] [Related]
17. Global hemostatic assay of different target procoagulant activities of factor VIII and factor IX.
Yoo KY; Jung SY; Hwang SH; Lee SM; Park JH; Nam HJ
Blood Res; 2018 Mar; 53(1):41-48. PubMed ID: 29662861
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis.
Matsumoto T; Nogami K; Shima M
Thromb Haemost; 2013 Oct; 110(4):761-8. PubMed ID: 24072166
[TBL] [Abstract][Full Text] [Related]
19. Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A.
Agosti P; Siboni SM; Scardo S; Torri A; Gualtierotti R; Peyvandi F
Blood Adv; 2023 Dec; 7(23):7209-7215. PubMed ID: 37871302
[TBL] [Abstract][Full Text] [Related]
20. Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
Luna-Záizar H; Beltrán-Miranda CP; Esparza-Flores MA; Soto-Padilla J; Bergés-García A; Rodríguez-Zepeda MD; Pompa-Garza MT; Jaloma-Cruz AR
Haemophilia; 2014 Jan; 20(1):e7-14. PubMed ID: 24354488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
